Guiding advanced therapy programs through complexity, with confidence.

Advise

Clarifying complex regulatory, scientific, clinical, quality and safety expectations from early-stage to commercial.

• Early visibility into CGT specific regulatory, quality, safety, and operational risk
• Phase appropriate guidance aligned to CGT modality, program maturity, and development stage
• Identification of critical decisions that shape downstream activities
• Alignment with geographic and jurisdictional expectations (FDA, EMA, global health authorities)

Enable

Aligning your product lifecycle, regulatory requirements and business needs into tangible roadmaps and strategies.

• Translation of CGT and ATMP regulatory and safety insights into one cohesive strategy
• Design governance and workflows purpose-built for cell and gene therapy inspection readiness
• CGT-specific roadmaps defining what to build and when
• Scalable frameworks that support CGT & ATMP complexity

Implement

Providing expertise and helping hands to execute roadmaps and strategies.

• Embedded execution teams across CGT modalities aligned to accelerated delivery of strategies via FSP, T&M and fixed price delivery models
• Deployment of scalable phase appropriate CGT systems, process, and documentation (COI/COC, aseptic processing)
• Embedded CGT SMEs for closure of critical gaps in Manufacturing, Quality, Validation, Safety, and Regulatory expectations
• Management of cross-functional execution across complex CGT stakeholder networks

Sustain

Training and supporting everlasting change for our clients to be successful beyond our engagements.

• Ongoing advisory check-ins to reinforce regulatory and program decisions
• Role-based training to embed CGT and ATMP practices across teams
• Account-level governance and continuity support
• Access to industry expertise and strategic partnerships as needs evolve